364 related articles for article (PubMed ID: 26978565)
1. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis.
Wu JT; Jit M; Zheng Y; Leung K; Xing W; Yang J; Liao Q; Cowling BJ; Yang B; Lau EH; Takahashi S; Farrar JJ; Grenfell BT; Leung GM; Yu H
PLoS Med; 2016 Mar; 13(3):e1001975. PubMed ID: 26978565
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease.
Liu D; Leung K; Jit M; Yu H; Yang J; Liao Q; Liu F; Zheng Y; Wu JT
Clin Microbiol Infect; 2020 Mar; 26(3):373-380. PubMed ID: 31279839
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a national enterovirus 71 vaccination program in China.
Wang W; Song J; Wang J; Li Y; Deng H; Li M; Gao N; Zhai S; Dang S; Zhang X; Jia X
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005899. PubMed ID: 28892475
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017.
Qi L; Su K; Xia Y; Tang W; Shen T; Li Q
PLoS One; 2019; 14(11):e0225569. PubMed ID: 31774839
[TBL] [Abstract][Full Text] [Related]
5. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
Li T; Wang H; Lu Y; Li Q; Chen C; Wang D; Li M; Li Y; Lu J; Chen Z; Ma Y; Liu W; Ma M; Wu D; Lu J; Yang Z
Vaccine; 2018 Jun; 36(26):3772-3778. PubMed ID: 29776754
[TBL] [Abstract][Full Text] [Related]
6. Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis.
Du Z; Huang Y; Bloom MS; Zhang Z; Yang Z; Lu J; Xu J; Hao Y
Hum Vaccin Immunother; 2021 Jan; 17(1):217-223. PubMed ID: 32530733
[No Abstract] [Full Text] [Related]
7. Socioeconomic burden of hand, foot and mouth disease in children in Shanghai, China.
Wang ZL; Xia AM; Li YF; Su HL; Zhan LW; Chen YP; Xi Y; Zhao LF; Liu LJ; Xu ZY; Zeng M
Epidemiol Infect; 2016 Jan; 144(1):138-43. PubMed ID: 26159305
[TBL] [Abstract][Full Text] [Related]
8. [Research progress on immune efficacy, safety, vaccination intention and immunization strategy of domestic enterovirus 71 vaccine after its marketing].
Xu WJ; Chen EF
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):1010-1016. PubMed ID: 32907294
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009-2018.
Han Y; Chen Z; Zheng K; Li X; Kong J; Duan X; Xiao X; Guo B; Luan R; Long L
Pediatr Infect Dis J; 2020 Oct; 39(10):969-978. PubMed ID: 32433221
[TBL] [Abstract][Full Text] [Related]
10. Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011-2018: A Longitudinal Surveillance Study.
Head JR; Collender PA; Lewnard JA; Skaff NK; Li L; Cheng Q; Baker JM; Li C; Chen D; Ohringer A; Liang S; Yang C; Hubbard A; Lopman B; Remais JV
Clin Infect Dis; 2020 Dec; 71(12):3088-3095. PubMed ID: 31879754
[TBL] [Abstract][Full Text] [Related]
11. Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
Wu H; Xue M; Wu C; Lu Q; Ding Z; Wang X; Fu T; Yang K; Lin J
PLoS One; 2022; 17(9):e0274421. PubMed ID: 36126038
[TBL] [Abstract][Full Text] [Related]
12. Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province.
Wang Y; Meng F; Li J; Li G; Hu J; Cao J; Yu Q; Liang Q; Zhu F
Hum Vaccin Immunother; 2020 Jul; 16(7):1579-1585. PubMed ID: 32209003
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
[TBL] [Abstract][Full Text] [Related]
14. Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China.
Zheng Y; Jit M; Wu JT; Yang J; Leung K; Liao Q; Yu H
PLoS One; 2017; 12(9):e0184266. PubMed ID: 28934232
[TBL] [Abstract][Full Text] [Related]
15. Disease burden of enterovirus 71 in rural central China: A community-based survey.
Gan ZK; Jin H; Li JX; Yao XJ; Zhou Y; Zhang XF; Zhu FC
Hum Vaccin Immunother; 2015; 11(10):2400-5. PubMed ID: 26158689
[TBL] [Abstract][Full Text] [Related]
16. The impact of enterovirus A71 vaccination program on hand, foot, and mouth disease in Guangdong, China: A longitudinal surveillance study.
Xiao J; Zhu Q; Yang F; Zeng S; Zhu Z; Gong D; Li Y; Zhang L; Li B; Zeng W; Li X; Rong Z; Hu J; He G; Sun J; Lu J; Liu T; Ma W; Sun L
J Infect; 2022 Oct; 85(4):428-435. PubMed ID: 35768049
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the vaccination status of enterovirus type 71 inactivated vaccine in China from 2017 to 2021].
Zhang L; Cao L; Li Y; Hu YX; Tang L; Li KL; Yin ZD; An ZJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Apr; 44(4):561-567. PubMed ID: 37147826
[No Abstract] [Full Text] [Related]
18. Effect of enterovirus 71 vaccination on the epidemiological characteristics and etiology in hospitalized children with hand-foot-and-mouth disease: A retrospective study from a tertiary children's hospital.
Sun J; Li Y; Yang Z; Fang Q; Chen B
Medicine (Baltimore); 2022 Sep; 101(37):e30356. PubMed ID: 36123878
[TBL] [Abstract][Full Text] [Related]
19. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
20. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
